AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 10.8013 USD -0.81%
Market Cap: 478.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one AXGN stock under the Base Case scenario is 12.1821 USD. Compared to the current market price of 10.8013 USD, AxoGen Inc is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AXGN Relative Value
Base Case
12.1821 USD
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
76
vs Industry
28
Median 3Y
2.8
Median 5Y
3.2
Industry
2.2
Forward
2.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-16.2
Median 5Y
-16.5
Industry
22
Forward
51.4
More Details
135.7
P/OCF
P/OCF
Price to OCF
135.7
vs History
7
vs Industry
1
Median 3Y
-28.6
Median 5Y
-31.9
Industry
13.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-13.4
Industry
19.5
More Details
4.7
P/B
P/B
Price to Book Value
4.7
vs History
36
vs Industry
8
Median 3Y
4
Median 5Y
4.1
Industry
2.1
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
68
vs Industry
26
Median 3Y
2.8
Median 5Y
3
Industry
2.4
Forward
2.4
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
53
vs Industry
37
Median 3Y
3.5
Median 5Y
3.8
Industry
4.9
More Details
70.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
70.1
vs History
7
vs Industry
1
Median 3Y
-16.7
Median 5Y
-17.4
Industry
11.7
Forward
18.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-16
Median 5Y
-16.4
Industry
15.9
Forward
186.8
More Details
143.9
EV/OCF
EV/OCF
Enterprise Value to OCF
143.9
vs History
7
vs Industry
1
Median 3Y
-30.4
Median 5Y
-31
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
100
Median 3Y
-12.4
Median 5Y
-12.4
Industry
17.3
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
52
vs Industry
12
Median 3Y
3.1
Median 5Y
3.8
Industry
1.8
More Details

Multiples Across Competitors

AXGN Competitors Multiples
AxoGen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
AxoGen Inc
NASDAQ:AXGN
495.6m USD 2.5 -68.6 70.1 -1 343.6
US
Abbott Laboratories
NYSE:ABT
231.3B USD 5.5 17.1 22.2 31.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
198B USD 22.7 79.9 64.5 78.4
US
Boston Scientific Corp
NYSE:BSX
155.7B USD 8.9 76.6 36.1 50.2
US
Stryker Corp
NYSE:SYK
146.2B USD 6.3 51.1 25.3 30.5
IE
Medtronic PLC
NYSE:MDT
106.4B USD 3.2 22.8 12.8 18.3
DE
Siemens Healthineers AG
XETRA:SHL
51.2B EUR 2.2 24.5 13.8 19.1
US
Becton Dickinson and Co
NYSE:BDX
49.5B USD 2.4 32.6 13 24.4
US
Edwards Lifesciences Corp
NYSE:EW
46B USD 8.3 11 25.2 27.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.4B USD 10.5 46.3 32.9 36.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
273.9B CNY 7.7 24.6 21.5 21.5

See Also

Summary
AXGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXGN stock valuation using valuation multiples.
Wall Street Estimates
AXGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 258,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.